BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35403259)

  • 21. Correlation of glymphatic system abnormalities with Parkinson's disease progression: a clinical study based on non-invasive fMRI.
    Meng JC; Shen MQ; Lu YL; Feng HX; Chen XY; Xu DQ; Wu GH; Cheng QZ; Wang LH; Gui Q
    J Neurol; 2024 Jan; 271(1):457-471. PubMed ID: 37755462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association Between Perivascular Spaces and Cerebral Blood Flow, Brain Volume, and Cardiovascular Risk.
    Liu S; Hou B; You H; Zhang Y; Zhu Y; Ma C; Zuo Z; Feng F
    Front Aging Neurosci; 2021; 13():599724. PubMed ID: 34531732
    [No Abstract]   [Full Text] [Related]  

  • 23. MRI-visible perivascular spaces in basal ganglia but not centrum semiovale or hippocampus were related to deep medullary veins changes.
    Zhang K; Zhou Y; Zhang W; Li Q; Sun J; Lou M
    J Cereb Blood Flow Metab; 2022 Jan; 42(1):136-144. PubMed ID: 34431378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI-visible perivascular space volumes, sleep duration and daytime dysfunction in adults with cerebrovascular disease.
    Ramirez J; Holmes MF; Berezuk C; Kwan D; Tan B; Beaton D; Scott CJM; Ozzoude M; Gao F; Yu D; Swardfager W; Lawrence-Dewar J; Dowlatshahi D; Saposnik G; Boulos MI; Murray BJ; Symons S; Bartha R; Black SE; Swartz RH; ; Lim A
    Sleep Med; 2021 Jul; 83():83-88. PubMed ID: 33991894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal-sized basal ganglia perivascular space related to motor phenotype in Parkinson freezers.
    Lv W; Yue Y; Shen T; Hu X; Chen L; Xie F; Zhang W; Zhang B; Gui Y; Lai HY; Ba F
    Aging (Albany NY); 2021 Jul; 13(14):18912-18923. PubMed ID: 34314380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability.
    Potter GM; Chappell FM; Morris Z; Wardlaw JM
    Cerebrovasc Dis; 2015; 39(3-4):224-31. PubMed ID: 25823458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of perivascular space visualization in basal ganglia and white matter hyperintensity lesion is a meaningful finding for subsequent cognitive decline.
    Sugai Y; Hiraka T; Shibata A; Taketa A; Tanae T; Moriya Y; Ohara S; Iseki C; Ohta Y; Kanoto M
    Acta Radiol; 2024 Jun; ():2841851241256778. PubMed ID: 38841771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enlarged perivascular spaces are linked to freezing of gait in Parkinson's disease.
    Lin F; Yang B; Chen Y; Zhao W; Li B; Jia W
    Front Neurol; 2022; 13():985294. PubMed ID: 36062021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enlarged Perivascular Spaces and Cerebral Small Vessel Disease in Spontaneous Intracerebral Hemorrhage Patients.
    Wang X; Feng H; Wang Y; Zhou J; Zhao X
    Front Neurol; 2019; 10():881. PubMed ID: 31474932
    [No Abstract]   [Full Text] [Related]  

  • 30. Association between visualization of the perivascular space and morphological changes in the brain among the community-dwelling elderly.
    Sugai Y; Niino K; Shibata A; Hiraka T; Kobayashi A; Suzuki K; Iseki C; Ohta Y; Kanoto M
    Eur J Radiol; 2023 May; 162():110792. PubMed ID: 36965287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson's disease.
    Fang Y; Gu LY; Tian J; Dai SB; Chen Y; Zheng R; Si XL; Jin CY; Song Z; Yan YP; Yin XZ; Pu JL; Zhang BR
    Aging (Albany NY); 2020 Nov; 12(24):25805-25818. PubMed ID: 33234732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enlarged Basal Ganglia Perivascular Spaces are Associated with Pulsatile Components of Blood Pressure.
    Del Brutto OH; Mera RM;
    Eur Neurol; 2018; 79(1-2):86-89. PubMed ID: 29316559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory motor dysfunction in parkinson's disease subtypes.
    Gong T; Xiang Y; Saleh MG; Gao F; Chen W; Edden RAE; Wang G
    J Magn Reson Imaging; 2018 Jun; 47(6):1610-1615. PubMed ID: 28960581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topography and associations of perivascular spaces in healthy adults: the Kashima scan study.
    Yakushiji Y; Charidimou A; Hara M; Noguchi T; Nishihara M; Eriguchi M; Nanri Y; Nishiyama M; Werring DJ; Hara H
    Neurology; 2014 Dec; 83(23):2116-23. PubMed ID: 25361776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
    Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
    Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson's disease.
    Shen T; Yue Y; Ba F; He T; Tang X; Hu X; Pu J; Huang C; Lv W; Zhang B; Lai HY
    NPJ Parkinsons Dis; 2022 Dec; 8(1):174. PubMed ID: 36543809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choroid plexus calcifications are not associated with putative markers of glymphatic dysfunction: A population study in middle-aged and older adults.
    Castillo PR; Patel V; Mera RM; Rumbea DA; Del Brutto OH
    Neuroradiol J; 2024 Jun; 37(3):342-350. PubMed ID: 38490679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
    Simuni T; Brumm MC; Uribe L; Caspell-Garcia C; Coffey CS; Siderowf A; Alcalay RN; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Nudelman K; Tosun-Turgut D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Bressman S; Marek K;
    Mov Disord; 2020 May; 35(5):833-844. PubMed ID: 32073681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI-visible perivascular spaces: relationship to cognition and small vessel disease MRI markers in ischaemic stroke and TIA.
    Hurford R; Charidimou A; Fox Z; Cipolotti L; Jager R; Werring DJ
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):522-5. PubMed ID: 24249785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.